GoKawiil
Tech News
Northwestern University reproductive biologist Francesca Duncan studied ovarian tissue from postmenopausal women aged 50 to 75 and found the protein composition varied significantly across age groups, rather than staying static as assumed. The findings suggest the ovary continues undergoing biological changes for decades after fertility and hormone production have ended.
Oura is extending its Menopause Impact Scale, a self-reported questionnaire it launched in May that measures how menopause symptoms affect quality of life, beyond its own app. Ten partners—including Alloy Health, Gennev, Wisp, Pomelo, Maven, Tia, Xella, Oova, Mira and Hertility—will now integrate the scoring tool into their care and tracking services. The scale evaluates 22 symptoms across seven categories such as sleep, cognition, body image and hot flashes, and results can be exported as a PDF to share with providers.
A feature traces the experience of Lisa Schrenk, a federal IT worker who battled severe mood symptoms and suicidal thoughts before learning from fellow hikers about hormone therapy for perimenopause. Her account illustrates a broader trend of women turning to hormone treatments after standard care, including oral contraceptives, failed to address their symptoms, often after doctors dismissed their concerns.